# The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation

> **NCT00579098** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 125 (actual)

## Conditions studied

- Atrial Fibrillation
- Arrhythmia
- Inflammation
- Endothelial Dysfunction

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00579098
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2014-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579098, "The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00579098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*